SIMION, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 591
AS - Asia 161
EU - Europa 130
OC - Oceania 7
SA - Sud America 1
Totale 890
Nazione #
US - Stati Uniti d'America 587
SG - Singapore 94
CN - Cina 64
IT - Italia 41
FI - Finlandia 36
FR - Francia 12
GB - Regno Unito 10
UA - Ucraina 9
DE - Germania 8
AU - Australia 7
NL - Olanda 5
SE - Svezia 4
HN - Honduras 3
IE - Irlanda 3
IN - India 3
CL - Cile 1
GR - Grecia 1
PA - Panama 1
PL - Polonia 1
Totale 890
Città #
Chandler 102
Singapore 83
Santa Clara 54
Fairfield 52
Ashburn 50
Helsinki 33
Beijing 25
Cambridge 23
Woodbridge 23
Boardman 22
Seattle 21
Wilmington 21
Houston 18
Medford 14
Princeton 14
Ann Arbor 11
San Diego 9
Mykolayiv 8
Roxbury 8
Sydney 7
London 6
New York 6
Legnaro 5
Des Moines 4
Milan 4
Padova 4
Falkenstein 3
Los Angeles 3
Amsterdam 2
Atlanta 2
Avellino 2
Bari 2
Coimbatore 2
Dallas 2
Lappeenranta 2
Novara 2
Shenyang 2
Tegucigalpa 2
Turin 2
Chicago 1
Dalian 1
Edinburgh 1
Gassino Torinese 1
Hebei 1
Hefei 1
Hounslow 1
Istrana 1
Kharkiv 1
Ningbo 1
Norwalk 1
Nürnberg 1
Panama City 1
Prescot 1
Pune 1
Salzano 1
San Pedro Sula 1
Southall 1
Tolbert 1
Zogno 1
Totale 675
Nome #
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 101
More severe hypercoagulable state in acute COVID-19 pneumonia as compared to other pneumonia 95
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 72
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis 71
Incidence of VTE in asymptomatic children with deficiencies of antithrombin, protein C, and protein S: a prospective cohort study 67
Risk Factors for Post-Thrombotic Syndrome in Patients With a First Proximal Deep Venous Thrombosis Treated With Direct Oral Anticoagulants 50
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review 49
Prothrombotic risk factors in pregnancy 47
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review 44
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 40
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19 40
Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project 34
Evaluation of Covid-19-Associated Hypercoagulability with Functional Coagulation Assays and Extracellular Vesicles 33
Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation 32
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 30
Mechanisms of thrombosis in pancreatic ductal adenocarcinoma 27
Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection 24
Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis 14
POST-discharge thromboprophylaxis in patients with COVID-19: a single-center experience 14
Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project 13
Portal Vein Thrombosis: State-of-the-Art Review 8
Totale 905
Categoria #
all - tutte 6.021
article - articoli 6.021
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 0 2 4 5 7 3 0 2
2020/2021118 0 2 0 0 49 7 5 11 15 12 14 3
2021/2022125 0 0 6 1 11 9 2 20 14 3 12 47
2022/2023207 33 24 5 17 30 19 2 16 40 3 11 7
2023/2024190 2 25 13 24 14 49 23 1 4 4 12 19
2024/2025221 1 59 31 16 90 24 0 0 0 0 0 0
Totale 905